BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30834603)

  • 1. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
    Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
    Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
    J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.
    Miao K; Liu SD; Huang WX; Dong H
    Pharmacology; 2020; 105(7-8):477-487. PubMed ID: 32454494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPEB3 overexpression caused by miR-106b-5p inhibition inhibits esophageal carcinoma in-vitro progression and metastasis.
    Wang H; Peng D; Gan M; He Z; Kuang Y
    Anticancer Drugs; 2022 Apr; 33(4):335-351. PubMed ID: 35102025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.
    Wang Y; Yan S; Liu X; Zhang W; Li Y; Dong R; Zhang Q; Yang Q; Yuan C; Shen K; Kong B
    Oncol Rep; 2014 Apr; 31(4):1905-10. PubMed ID: 24573236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
    Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
    Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
    Zheng H; Bai L
    Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p.
    Mei J; Huang Y; Hao L; Liu Y; Yan T; Qiu T; Xu R; Xu B; Xiao Z; Jiang X; Hu K; Zhu Y
    Pathol Res Pract; 2019 Jul; 215(7):152452. PubMed ID: 31104928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q; Wang L; Zhu L; Lu X; Song Y; Sun J; Wu Z; Shi J; Wang Z; Zhou X
    Gene; 2019 Sep; 713():143969. PubMed ID: 31299360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
    Pan L; Meng Q; Li H; Liang K; Li B
    Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01089, suppressed by YY1, inhibits lung cancer progression by targeting miR-301b-3p/HPDG axis.
    Yang R; Liu Z; Cao H; Shi Y
    Cell Biol Toxicol; 2022 Dec; 38(6):1063-1077. PubMed ID: 34561789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.
    Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H
    Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.
    Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J
    Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
    Lu X; Duan J; Zhou R; Xu Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):35-44. PubMed ID: 34369713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.